V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10047815 | 10054732 | 1.57 | 77.9 | null | 2021-10-08 | 2022-04-08 | Avelumab | 02 | null | AVELUMAB | 101098508 |
| 10048081 | 10054734 | 1.79 | 45.8 | Adjuvant (A) | 2016-09-08 | 2018-10-29 | Irinotecan + Modified De Gramont | N | N | FLUOROURACIL + IRINOTECAN | 100970970 |
| 10049798 | 10054736 | null | 70.6 | null | 2020-06-01 | 2020-12-16 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100625952 |
| 10049955 | 10054737 | 1.81 | 88.4 | Palliative (P) | 2017-11-16 | 2018-11-03 | Avelumab | 02 | N | AVELUMAB | 100427532 |
| 10051750 | 10054740 | 1.82 | 44.6 | Adjuvant (A) | 2018-08-12 | 2018-08-13 | Venetoclax | 02 | null | VENETOCLAX | 100309116 |
| 10053563 | 10054742 | 1.49 | 96.65 | null | 2018-09-23 | 2020-02-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101500747 |
| 10055637 | 10054745 | null | 68.1 | 03 | 2020-06-03 | 2020-07-02 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101433600 |
| 10055773 | 10054747 | 1.7 | 58.2 | null | 2019-07-30 | 2019-08-03 | Trastuzumab | 02 | null | TRASTUZUMAB | 101416855 |
| 10055776 | 10054748 | 1.62 | 57.65 | null | 2022-01-16 | 2022-02-06 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101462038 |
| 10058316 | 10054750 | 1.75 | 76.6 | Adjuvant (A) | 2020-04-24 | 2020-04-28 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101355487 |
| 10058477 | 10054751 | 1.58 | 84.9 | Palliative (P) | null | 2016-01-16 | Trastuzumab | 02 | N | TRASTUZUMAB | 101737185 |
| 10060496 | 10054753 | 1.66 | 64.6 | null | 2017-01-06 | 2017-02-03 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101017976 |
| 10062079 | 10054755 | 1.75 | 77.9 | null | 2019-10-22 | 2019-10-30 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100425559 |
| 10064100 | 10054757 | 1.72 | 61.2 | null | 2017-07-12 | 2017-07-22 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100807441 |
| 10065800 | 10054758 | 1.73 | 97.65 | null | 2017-09-21 | 2017-12-07 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101367135 |
| 10067204 | 10054759 | 1.74 | 93.1 | null | 2013-11-14 | 2017-05-16 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100327208 |
| 10068643 | 10054760 | 1.65 | 92 | Palliative (P) | null | 2021-10-19 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101443824 |
| 10070902 | 10054762 | 1.56 | 86.6 | null | null | 2018-07-27 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100591661 |
| 10072182 | 10054764 | null | 87.2 | null | 2018-02-04 | 2018-02-22 | Venetoclax | 02 | null | VENETOCLAX | 100342992 |
| 10072681 | 10054765 | 1.62 | 79.5 | 03 | 2021-07-10 | 2021-09-05 | Venetoclax | N | N | VENETOCLAX | 100635331 |
| 10072850 | 10054766 | 1.83 | null | null | 2021-01-20 | 2021-02-02 | Avelumab | 02 | null | RUXOLITINIB | 101453929 |
| 10073652 | 10054767 | 1.83 | 93.2 | Palliative (P) | null | 2019-10-12 | Avelumab | 02 | N | RUXOLITINIB | 101210565 |
| 10075178 | 10054769 | null | 75 | Palliative (P) | 2019-04-17 | 2019-04-27 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101049512 |
| 10075720 | 10054771 | 0 | null | null | 2019-09-27 | 2019-10-02 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100030627 |
| 10075728 | 10054772 | 1.75 | 84.55 | null | 2019-07-03 | 2019-07-10 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100597874 |
| 10075965 | 10054773 | 1.62 | 77.8 | Palliative (P) | 2021-01-24 | 2021-02-11 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101443077 |
| 10076203 | 10054774 | 1.55 | 76.9 | Palliative (P) | 2019-09-20 | 2019-09-28 | Avelumab | 02 | N | AVELUMAB | 100801340 |
| 10076213 | 10054775 | 1.66 | 52.1 | null | 2016-06-29 | 2016-07-12 | CEMIPLIMAB | N | null | CEMIPLIMAB | 100544266 |
| 10076780 | 10054776 | 1.63 | 96.2 | Palliative (P) | 2018-05-31 | 2018-06-07 | Avelumab | 02 | N | AVELUMAB | 101341124 |
| 10078362 | 10054778 | 1.64 | 78.8 | null | null | 2022-03-01 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101363598 |
| 10078977 | 10054779 | 1.65 | 68.8 | null | null | 2017-06-18 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100910016 |
| 10079881 | 10054782 | 1.75 | 63.8 | null | null | 2020-11-08 | CEMIPLIMAB | N | null | CEMIPLIMAB | 101736314 |
| 10080967 | 10054783 | 1.76 | 101.3 | null | 2018-09-16 | 2018-09-19 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101637431 |
| 10081436 | 10054784 | 1.7 | 75.7 | null | 2018-02-03 | 2019-02-15 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100445042 |
| 10084010 | 10054786 | 1.55 | 77.9 | 03 | 2017-10-15 | 2019-05-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101284644 |
| 10085276 | 10054788 | 1.77 | 79.7 | null | 2019-10-03 | 2019-10-13 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100955074 |
| 10085293 | 10054789 | 0 | 74.6 | 03 | 2021-05-19 | 2021-05-26 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101221821 |
| 10085784 | 10054790 | 1.72 | 93.8 | null | 2019-10-01 | 2019-10-05 | DARATUMUMAB | 02 | null | CAPECITABINE + OXALIPLATIN | 101350165 |
| 10087201 | 10054791 | 1.62 | 78.6 | Palliative (P) | null | 2019-07-11 | Avelumab | null | N | TRASTUZUMAB | 100557359 |
| 10088119 | 10054792 | null | 70.9 | null | null | 2017-03-23 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100519128 |
| 10088269 | 10054793 | 0 | 87 | Palliative (P) | 2021-12-29 | 2022-01-06 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100491814 |
| 10089404 | 10054794 | 1.7 | 66.9 | Palliative (P) | null | 2020-03-21 | Trastuzumab | 02 | N | CAPECITABINE + OXALIPLATIN | 100052302 |
| 10089425 | 10054795 | 1.74 | 56 | Palliative (P) | null | 2018-09-06 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101192362 |
| 10090117 | 10054796 | 1.69 | 87 | Palliative (P) | 2018-02-03 | 2018-02-10 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101491205 |
| 10090872 | 10054797 | 1.72 | 62.7 | null | 2017-10-18 | 2018-01-29 | Avelumab | 02 | null | AVELUMAB | 101735264 |
| 10091197 | 10054798 | 1.62 | 74.4 | Disease modification (D) | 2018-08-21 | 2018-09-16 | Avelumab | 02 | N | NIVOLUMAB | 101301313 |
| 10092366 | 10054799 | 1.47 | 56 | null | 2017-09-19 | 2017-10-03 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100089556 |
| 10093965 | 10054800 | 1.76 | 79.9 | Palliative (P) | 2018-03-08 | 2018-03-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101386558 |
| 10094433 | 10054801 | 1.62 | 121.6 | 03 | 2018-12-09 | 2018-12-16 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101151816 |
| 10094662 | 10054802 | 1.62 | 58.5 | 03 | 2020-05-11 | 2020-05-11 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100723532 |